 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The meeting of the Board of Directors of the Company held today, i.e. on Friday June 27, 2014 has considered and approved the issue of 34,54,913 equity shares consequent to the conversion notice(s) received from the Bondholder for conversion of the Foreign Currency Convertible Bonds ("FCCB") for total value of US$ 3.50 million at a conversion price of Rs. 55 per share, in accordance with the terms of the Offering Circular dated March 21,2013 for issue of US$40 million unsecured foreign currency convertible bonds and the Supplemental Trust Deed dated February 21,2014.
The allotment of 3454913 shares was made to Auctor Investments Ltd.
Shares of Dr.Datsons Labs Limited was last trading in BSE at Rs.15.9 as compared to the previous close of Rs. 16.25. The total number of shares traded during the day was 276022 in over 1635 trades.
The stock hit an intraday high of Rs. 16.25 and intraday low of 15.55. The net turnover during the day was Rs. 4400383.